EDGAR Filing Documents for 0001144204-17-041706

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001144204-17-041706

Filing Date

2017-08-09

Accepted

2017-08-09 16:27:17

Documents

Period of Report

2017-06-30

Document Format Files

Seq	Description	Document	Type	Size
1	10-Q	v472128_10q.htm	10-Q	707689
2	EX-10.57	v472128_ex10-57.htm	EX-10.57	132283
3	EX-10.58	v472128_ex10-58.htm	EX-10.58	22935
4	EX-10.59	v472128_ex10-59.htm	EX-10.59	19838
5	EXHIBIT 31.1	v472128_ex31-1.htm	EX-31.1	10025
6	EXHIBIT 31.2	v472128_ex31-2.htm	EX-31.2	10025
7	EXHIBIT 32.1	v472128_ex32-1.htm	EX-32.1	4012
8	EXHIBIT 32.2	v472128_ex32-2.htm	EX-32.2	4053
	Complete submission text file	0001144204-17-041706.txt		6560536

Data Files

Seq	Description	Document	Type	Size
9	XBRL INSTANCE DOCUMENT	eltp-20170630.xml	EX-101.INS	1481043
10	XBRL TAXONOMY EXTENSION SCHEMA	eltp-20170630.xsd	EX-101.SCH	66974
11	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	eltp-20170630_cal.xml	EX-101.CAL	39702
12	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	eltp-20170630_def.xml	EX-101.DEF	398498
13	XBRL TAXONOMY EXTENSION LABEL LINKBASE	eltp-20170630_lab.xml	EX-101.LAB	442963
14	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	eltp-20170630_pre.xml	EX-101.PRE	460105

Mailing Address 165 LUDLOW AVENUE NORTHVALE NJ 07647

Business Address 165 LUDLOW AVENUE NORTHVALE NJ 07647 2017502646

ELITE PHARMACEUTICALS INC /NV/ (Filer) CIK: 0001053369 (see all company filings)